Commonly reported issues include: Gastrointestinal Distress: Nausea, vomiting, and diarrhea are common, particularly when starting the medication
Noom was previously offering microdoses of compounded GLP-1 semaglutide for weight loss for people with a BMI of 25 or higher
Lilly's Zepbound (tirzepatide) superior to Wegovy (semaglutide) in head-to-head trial showing an average weight loss of 20.2% vs
Pereira-Miranda, E., Costa, P
This amount is often enough to support fullness while helping preserve lean muscle massparticularly important during weight loss or healthy aging
Similar results were observed in an experiment involving a germ-free mouse strain, where the animals transplanted with microbiome isolated from depressed patients showed an increase in immobility time in the forced swim test and a decreased proportion of central motion distance in the open field test, compared to mice transplanted with bacteria obtained from healthy control subjects [101]
